The Dublin-based company plans to relocate some existing U.S. operations to the new 600,000-square-foot campus in the coming years.
An article from
Dive Brief
The Dublin-based company plans to relocate some existing U.S. operations to the new 600,000-square-foot campus in the coming years.
Published Aug. 6, 2026
A pharmacist takes inventory of prescription drug cartons using a digital tablet. Chemicals maker Steris plans to invest $600 million to build a manufacturing and distribution hub in Sanford, North Carolina.
The plasma-derived medicine maker plans to create 1,500 jobs to support one of the state’s largest private biomedical investments.
The planned logistics site, near a principal manufacturing facility, will handle global distribution of Boston Scientific’s…
Gerresheimer sells Centor and PPP unit to Apax Funds for €1.5B; Resilience and Lilly invest $750M in Ohio manufacturing; Teva…
South Korean biopharmaceutical company Celltrion said it would invest at least $1 billion to acquire a plant from Eli Lilly in…
La nueva planta de Boston Scientific, multinacional de dispositivos médicos, brinda espacio de manufactura avanzada con un…
Eighteen months after Novo Nordisk purchased a plant in the | Eighteen months after Novo Nordisk purchased a plant in the Czech…
